Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Stephanie Berg is a medical oncologist for the Lank Center of Genitourinary Oncology. She completed her medical education at the Lake Erie College of Osteopathic Medicine. Her post-graduate training in Internal Medicine was completed at the University of Illinois-Chicago where she served as Chief Resident and hematology-oncology fellowship at Loyola University Medical Center where she served as Chief Fellow. She was an Assistant Professor of Medicine at Loyola University Chicago in the Department of Medicine and Cancer Biology from 2018-2022. Prior to her arrival at Dana-Farber Cancer Institute, she was the junior faculty lead of the Genitourinary Medical Oncology Program at the Cardinal Bernardin Cancer Center of Loyola University Chicago. She was also the research head of Renal Cell Cancer clinical trials and served as the principal investigator on several cooperative group and industry sponsored trials. Her aim is to be at the forefront of translating basic science research to better understand the pathogenesis of cancer development, participate in novel gene discovery and identify potential molecular therapeutic targets for future genitourinary cancer treatment. She has a special interest in older adult oncology and novel immunotherapy drug development.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions